Amarin's focus on the fundamentals of running a biotech business pays off.
UnitedHealth, WellPoint, and other health insurers have seen their stocks jump over the past year, but they've given back some ground lately. Is Obamacare to blame?
Will ObamaCare fundamentally change how managed-care companies like UnitedHealth, Cigna, Aetna, and WellPoint operate?
Walgreen jumps aboard the corporate health plan privatization bandwagon. Find out how this move could be a win-win for investors and employees -- and the gigantic unanswered question it presents.
Despite the markets moving higher after the no-taper vote, health-care stocks tumble.
The nation's jobs picture might be cloudy, but this sector stands out as a silver lining.
Can Medtronic’s recent acquisition of Cardiocom protect it from trends affecting the medical device industry?
Quest Diagnostics represents good value, and its earnings growth prospects are largely over its internal execution.
A new study from the Kaiser Family Foundation reveals unexpected news just over three weeks before the opening of state-run health exchanges.
An Obamacare study by an independent research firm concludes that both insurance carriers and customers seem to benefit from the new rules.